AG
Artal Group’s Lexicon Pharmaceuticals LXRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $129M | Hold |
136,180,481
| – | – | 13.91% | 2 |
|
2025
Q1 | $62.6M | Hold |
136,180,481
| – | – | 7.08% | 2 |
|
2024
Q4 | $101M | Hold |
136,180,481
| – | – | 8.59% | 2 |
|
2024
Q3 | $214M | Sell |
136,180,481
-38,918,903
| -22% | -$61.1M | 8.98% | 2 |
|
2024
Q2 | $294M | Buy |
175,099,384
+57,546,100
| +49% | +$96.7M | 7.5% | 2 |
|
2024
Q1 | $282M | Hold |
117,553,284
| – | – | 7.19% | 2 |
|
2023
Q4 | $180M | Hold |
117,553,284
| – | – | 5.98% | 3 |
|
2023
Q3 | $128M | Hold |
117,553,284
| – | – | 5.49% | 2 |
|
2023
Q2 | $269M | Buy |
117,553,284
+27,775,050
| +31% | +$63.6M | 8.34% | 2 |
|
2023
Q1 | $218M | Hold |
89,778,234
| – | – | 12.96% | 1 |
|
2022
Q4 | $171M | Hold |
89,778,234
| – | – | 9.57% | 1 |
|
2022
Q3 | $215M | Buy |
89,778,234
+18,599,870
| +26% | +$44.6M | 9.2% | 1 |
|
2022
Q2 | $132M | Hold |
71,178,364
| – | – | 7.07% | 2 |
|
2022
Q1 | $149M | Hold |
71,178,364
| – | – | 6.23% | 3 |
|
2021
Q4 | $280M | Hold |
71,178,364
| – | – | 7.61% | 1 |
|
2021
Q3 | $342M | Hold |
71,178,364
| – | – | 7.66% | 1 |
|
2021
Q2 | $327M | Hold |
71,178,364
| – | – | 6.63% | 2 |
|
2021
Q1 | $418M | Hold |
71,178,364
| – | – | 7.38% | 2 |
|
2020
Q4 | $243M | Buy |
71,178,364
+10,937,500
| +18% | +$37.4M | 5.23% | 4 |
|
2020
Q3 | $86.7M | Hold |
60,240,864
| – | – | 2.11% | 8 |
|
2020
Q2 | $120M | Hold |
60,240,864
| – | – | 3.36% | 6 |
|
2020
Q1 | $117M | Hold |
60,240,864
| – | – | 4.96% | 5 |
|
2019
Q4 | $250M | Hold |
60,240,864
| – | – | 9.66% | 2 |
|
2019
Q3 | $181M | Hold |
60,240,864
| – | – | 7.27% | 2 |
|
2019
Q2 | $379M | Hold |
60,240,864
| – | – | 15.32% | 1 |
|
2019
Q1 | $335M | Hold |
60,240,864
| – | – | 13.68% | 1 |
|
2018
Q4 | $400M | Hold |
60,240,864
| – | – | 14.82% | 2 |
|
2018
Q3 | $643M | Hold |
60,240,864
| – | – | 16.72% | 2 |
|
2018
Q2 | $723M | Buy |
60,240,864
+1,966,214
| +3% | +$23.6M | 15.36% | 2 |
|
2018
Q1 | $499M | Hold |
58,274,650
| – | – | 6.25% | 3 |
|
2017
Q4 | $576M | Buy |
58,274,650
+756,673
| +1% | +$7.48M | 8.68% | 3 |
|
2017
Q3 | $707M | Hold |
57,517,977
| – | – | 12.18% | 3 |
|
2017
Q2 | $946M | Hold |
57,517,977
| – | – | 16.53% | 3 |
|
2017
Q1 | $825M | Hold |
57,517,977
| – | – | 18.31% | 2 |
|
2016
Q4 | $795M | Hold |
57,517,977
| – | – | 17.66% | 2 |
|
2016
Q3 | $1.04B | Hold |
57,517,977
| – | – | 20.58% | 2 |
|
2016
Q2 | $825M | Hold |
57,517,977
| – | – | 17.04% | 2 |
|
2016
Q1 | $687M | Hold |
57,517,977
| – | – | 13.41% | 2 |
|
2015
Q4 | $766M | Sell |
57,517,977
-1
| -0% | -$13 | 14.37% | 2 |
|
2015
Q3 | $618M | Hold |
57,517,978
| – | – | 13.8% | 2 |
|
2015
Q2 | $463M | Sell |
57,517,978
-345,107,888
| -86% | -$2.78B | 19.93% | 1 |
|
2015
Q1 | $378M | Hold |
402,625,866
| – | – | 17.5% | 1 |
|
2014
Q4 | $366M | Buy |
402,625,866
+149,253,731
| +59% | +$136M | 12.86% | 2 |
|
2014
Q3 | $357M | Hold |
253,372,135
| – | – | 13.15% | 2 |
|
2014
Q2 | $408M | Hold |
253,372,135
| – | – | 16.49% | 2 |
|
2014
Q1 | $438M | Hold |
253,372,135
| – | – | 15.87% | 2 |
|
2013
Q4 | $456M | Hold |
253,372,135
| – | – | 16.36% | 2 |
|
2013
Q3 | $603M | Hold |
253,372,135
| – | – | 19.63% | 2 |
|
2013
Q2 | $550M | Buy |
+253,372,135
| New | +$550M | 17.3% | 2 |
|